Endocytosis of Nanomedicines: The Case of Glycopeptide Engineered PLGA Nanoparticles

The success of nanomedicine as a new strategy for drug delivery and targeting prompted the interest in developing approaches toward basic and clinical neuroscience. Despite enormous advances on brain research, central nervous system (CNS) disorders remain the world’s leading cause of disability, in...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Pharmaceutics
Autors principals: Vilella, Antonietta, Ruozi, Barbara, Belletti, Daniela, Pederzoli, Francesca, Galliani, Marianna, Semeghini, Valentina, Forni, Flavio, Zoli, Michele, Vandelli, Maria Angela, Tosi, Giovanni
Format: Artigo
Idioma:Inglês
Publicat: MDPI 2015
Matèries:
Review
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4491652/
https://ncbi.nlm.nih.gov/pubmed/26102358
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/pharmaceutics7020074
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars